ARVEE2025-10-012025-12-31ARVEE2025-12-31ARVEE2025-04-012025-12-31ARVEE2025-10-012025-12-31in-capmkt:OtherExpenses1MemberARVEE2025-04-012025-12-31in-capmkt:OtherExpenses1MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-04-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-04-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-04-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-04-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-12-31in-capmkt:ReportableSegments1MemberARVEE2025-10-012025-12-31in-capmkt:ReportableSegments2MemberARVEE2025-12-31in-capmkt:ReportableSegments2Memberiso4217:INRiso4217:INRxbrli:shares000000ARVEENOTLISTEDINE006Z01016ARVEE LABORATORIES (INDIA) LIMITEDMain BoardEquity2025-04-012026-03-312026-02-132026-02-05INRLakhsQuarterlyThird quarterMulti segment2026-02-1317:00:002026-02-1318:15:00Not applicablefalsefalseNOT APPLICABLE TO US2025-10-012025-12-31UnauditedStandalone9779500013650009916000038285000097500001116700065900030290002234800085238000139220000139220002262000-6609000-4347000018269000000018269000018269000110200000101.661.66001.661.66The aforesaid Financial Results for the quarter and Nine Month ended December 31, 2025 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at its Meeting held on Friday, February 13, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the aforesaid results. <BR> <BR> The aforesaid Financial Results for the quarter and Nine Month ended December 31, 2025 have been prepared in accordance with Companies (Indian Accounting Standard) Rule, 2015 as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> In line with Ind AS - 108 Operating Segments and basis of the review of operations being done by the Senior Management, the operations of the Company fall under the Chemicals business which has been further segmented into Textile and Non Textile segment as reportable segment by the management. <BR> <BR> The Company does not have any subsidary or Joint venture or associate and hence consolidated results are not applicable. <BR> <BR> Earnings Per Share is not annualised for the quarter and Nine months ended on the periods mentioned in the above results. <BR> The figures for the corresponding Previous period have been restated / regrouped wherever necessary, to make them comparable.2025-04-012025-12-31UnauditedStandalone20710000053480002124480001327240000-49264000344800001531000899900068210000196680000157680000157680002315000-6609000-4294000020062000000020062000020062000110200000101.821.82001.821.82Other Expenses22348000Other Expenses68210000Textile Segment10971000Non - Textile Segment88188000Textile Segment29557000Non - Textile Segment1828910009915900021244800099159000212448000Textile Segment1605000Non - Textile Segment12694000Textile Segment2419000Non - Textile Segment14495000142990001691400037700011460001392200015768000Textile Segment113441000Non - Textile Segment2250780003385190000338519000Textile Segment113441000Non - Textile Segment2250780003385190000338519000